Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis

Bone Marrow Transplant. 2018 Jun;53(6):784-786. doi: 10.1038/s41409-018-0125-5. Epub 2018 Mar 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Busulfan / administration & dosage
  • Combined Modality Therapy
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Immunization, Passive / methods*
  • Lymphohistiocytosis, Hemophagocytic / drug therapy
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphohistiocytosis, Hemophagocytic / therapy*
  • Male
  • Transplantation Conditioning / methods*
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Vidarabine
  • Busulfan
  • fludarabine